Another day, another Form 483 for a Dr. Reddy's plant

FDA inspectors keep hitting replay for Dr. Reddy’s plants as they make their way through its manufacturing sites. They cite a facility and move on only to find India’s second-largest drugmaker making missteps at the next facility they check.